Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1990 Feb;211(2):202–210. doi: 10.1097/00000658-199002000-00013

Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts.

J V Reynolds 1, J M Daly 1, J Shou 1, R Sigal 1, M M Ziegler 1, A Naji 1
PMCID: PMC1357965  PMID: 2301998

Abstract

Supplemental dietary arginine has anti-tumor properties but the degree and mechanisms are unclear. In non-tumor-bearing CBA/J mice (n = 60), 1% arginine supplementation significantly enhanced thymic weight, spleen cell mitogenesis, and interferon-activated natural killer cell activity; no further enhancement was observed with 2% or 4% supplementation. Supplemental 1% arginine, when compared with 1.7% glycine, enhanced interferon-induced natural killer cell activity, lymphokine-activated killer cell generation, and macrophage cytotoxicity. In A/J mice (n = 420), bearing either a moderately immunogenic (C1300) or weakly immunogenic (TBJ) murine neuroblastoma, 1% arginine significantly (p less than 0.05) retarded tumor growth and prolonged median survival time compared with glycine or no supplementation. Dietary arginine enhanced T-cell function and significantly increased responsiveness to autologous C1300 tumor in a mixed lymphocyte tumor cell culture (MLTC). The immunomodulatory effects of arginine provide nutritional and immunologic support of the tumor-bearing host and may be helpful when given concommitant with immunotherapy.

Full text

PDF
202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr. 1986 Mar-Apr;10(2):227–238. doi: 10.1177/0148607186010002227. [DOI] [PubMed] [Google Scholar]
  2. Barbul A., Sisto D. A., Wasserkrug H. L., Yoshimura N. N., Efron G. Metabolic and immune effects of arginine in postinjury hyperalimentation. J Trauma. 1981 Nov;21(11):970–974. doi: 10.1097/00005373-198111000-00011. [DOI] [PubMed] [Google Scholar]
  3. Brennan M. F., Cerra F., Daly J. M., Fischer J. E., Moldawer L. L., Smith R. J., Vinnars E., Wannemacher R., Young V. R. Report of a research workshop: branched-chain amino acids in stress and injury. JPEN J Parenter Enteral Nutr. 1986 Sep-Oct;10(5):446–452. doi: 10.1177/0148607186010005446. [DOI] [PubMed] [Google Scholar]
  4. Cho-Chung Y. S., Clair T., Bodwin J. S., Hill D. M. Arrest of mammary tumor growth in vivo by L-arginine: stimulation of NAD-dependent activation of adenylate cyclase. Biochem Biophys Res Commun. 1980 Aug 14;95(3):1306–1313. doi: 10.1016/0006-291x(80)91616-2. [DOI] [PubMed] [Google Scholar]
  5. Daly J. M., Reynolds J., Thom A., Kinsley L., Dietrick-Gallagher M., Shou J., Ruggieri B. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1988 Oct;208(4):512–523. doi: 10.1097/00000658-198810000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farrar J. J., Benjamin W. R., Hilfiker M. L., Howard M., Farrar W. L., Fuller-Farrar J. The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev. 1982;63:129–166. doi: 10.1111/j.1600-065x.1982.tb00414.x. [DOI] [PubMed] [Google Scholar]
  7. Friedman A., Beller D. I. Simultaneous expression of Ia and cytocidal activity by macrophages, and the consequences for antigen presentation. Immunology. 1987 Aug;61(4):435–441. [PMC free article] [PubMed] [Google Scholar]
  8. Hibbs J. B., Jr, Taintor R. R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987 Jan 23;235(4787):473–476. doi: 10.1126/science.2432665. [DOI] [PubMed] [Google Scholar]
  9. Hibbs J. B., Jr, Vavrin Z., Taintor R. R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987 Jan 15;138(2):550–565. [PubMed] [Google Scholar]
  10. Iyengar R., Stuehr D. J., Marletta M. A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6369–6373. doi: 10.1073/pnas.84.18.6369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karpeh M. S., Kehne J. A., Choi S. H., Ziegler M. M. Tumor immunogenicity, nutritional repletion, and cancer. Surgery. 1987 Aug;102(2):283–290. [PubMed] [Google Scholar]
  12. LEVY H. M., MONTANEZ G., FEAVER E. R., MURPHY E. A., DUNN M. S. Effect of arginine on tumor growth in rats. Cancer Res. 1954 Mar;14(3):198–200. [PubMed] [Google Scholar]
  13. Merimee T. J., Lillicrap D. A., Rabinowitz D. Effect of arginine on serum-levels of human growth-hormone. Lancet. 1965 Oct 2;2(7414):668–670. doi: 10.1016/s0140-6736(65)90399-5. [DOI] [PubMed] [Google Scholar]
  14. Milner J. A., Stepanovich L. V. Inhibitory effect of dietary arginine on growth of Ehrlich ascites tumor cells in mice. J Nutr. 1979 Mar;109(3):489–494. doi: 10.1093/jn/109.3.489. [DOI] [PubMed] [Google Scholar]
  15. Moss J., Vaughan M. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J Biol Chem. 1977 Apr 10;252(7):2455–2457. [PubMed] [Google Scholar]
  16. Palmer J. P., Walter R. M., Ensinck J. W. Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Diabetes. 1975 Aug;24(8):735–740. doi: 10.2337/diab.24.8.735. [DOI] [PubMed] [Google Scholar]
  17. Rakoff J. S., Siler T. M., Sinha Y. N., Yen S. S. Prolactin and growth hormone release in response to sequential stimulation by arginine and synthetic TRF. J Clin Endocrinol Metab. 1973 Nov;37(5):641–644. doi: 10.1210/jcem-37-5-641. [DOI] [PubMed] [Google Scholar]
  18. Reynolds J. V., Daly J. M., Zhang S., Evantash E., Shou J., Sigal R., Ziegler M. M. Immunomodulatory mechanisms of arginine. Surgery. 1988 Aug;104(2):142–151. [PubMed] [Google Scholar]
  19. Reynolds J. V., Thom A. K., Zhang S. M., Ziegler M. M., Naji A., Daly J. M. Arginine, protein malnutrition, and cancer. J Surg Res. 1988 Dec;45(6):513–522. doi: 10.1016/0022-4804(88)90138-2. [DOI] [PubMed] [Google Scholar]
  20. Rose W. C. THE NUTRITIVE SIGNIFICANCE OF THE AMINO ACIDS AND CERTAIN RELATED COMPOUNDS. Science. 1937 Oct 1;86(2231):298–300. doi: 10.1126/science.86.2231.298. [DOI] [PubMed] [Google Scholar]
  21. Seifter E., Rettura G., Barbul A., Levenson S. M. Arginine: an essential amino acid for injured rats. Surgery. 1978 Aug;84(2):224–230. [PubMed] [Google Scholar]
  22. Smith K. A. Interleukin 2. Annu Rev Immunol. 1984;2:319–333. doi: 10.1146/annurev.iy.02.040184.001535. [DOI] [PubMed] [Google Scholar]
  23. Snow E. C. Insulin and growth hormone function as minor growth factors that potentiate lymphocyte activation. J Immunol. 1985 Aug;135(2 Suppl):776s–778s. [PubMed] [Google Scholar]
  24. Tabor C. W., Tabor H. Polyamines. Annu Rev Biochem. 1984;53:749–790. doi: 10.1146/annurev.bi.53.070184.003533. [DOI] [PubMed] [Google Scholar]
  25. Unanue E. R. Antigen-presenting function of the macrophage. Annu Rev Immunol. 1984;2:395–428. doi: 10.1146/annurev.iy.02.040184.002143. [DOI] [PubMed] [Google Scholar]
  26. Visek W. J. An update of concepts of essential amino acids. Annu Rev Nutr. 1984;4:137–155. doi: 10.1146/annurev.nu.04.070184.001033. [DOI] [PubMed] [Google Scholar]
  27. Windmueller H. G. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 1982;53:201–237. doi: 10.1002/9780470122983.ch6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES